UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 4.125

Sortiert nach

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2018-10, Vol.29 (Supplement_4), p.iv192-iv237

2018

Volltextzugriff (PDF)

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2016-09, Vol.27 (suppl 5), p.v1-v27

2016

Volltextzugriff (PDF)

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2014-09, Vol.25 Suppl 3, p.iii27-iii39

2014

Volltextzugriff (PDF)

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2022-02, Vol.33 (2), p.129-142

2022

Volltextzugriff (PDF)

Adjuvant immune checkpoint inhibitor therapy for resected non-small-cell lung cancer: dessert, starters, or a sandwich?

Annals of oncology, 2023-10, Vol.34 (10), p.829-830

2023

Volltextzugriff (PDF)

Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2013-10, Vol.24 Suppl 6, p.vi99-vi105

2013

Volltextzugriff (PDF)

Brain metastases in solid tumours: new guidelines for a new era

Annals of oncology, 2021-11, Vol.32 (11), p.1322-1324

2021

Volltextzugriff (PDF)

Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis

Journal of clinical oncology, 2005-01, Vol.23 (3), p.609-618

2005

Volltextzugriff (PDF)

ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group

Annals of oncology, 2022-08, Vol.33 (8), p.750-768

2022

Volltextzugriff (PDF)

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2019-05, Vol.30 (5), p.863-870

2019

Volltextzugriff (PDF)

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

Annals of oncology, 2019-08, Vol.30 (8), p.1321-1328

2019

Volltextzugriff (PDF)

A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial

Annals of oncology, 2020-12, Vol.31 (12), p.1734-1745

2020

Volltextzugriff (PDF)

First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743

Annals of oncology, 2022-05, Vol.33 (5), p.488-499

2022

Volltextzugriff (PDF)

FIELDimageR.Extra: Advancing user experience and computational efficiency for analysis of orthomosaic from agricultural field trials

Plant phenome journal, 2023-12, Vol.6 (1), p.n/a

2023

Volltextzugriff (PDF)

Efficient access to alkynylated quinalizinones via the gold(i)-catalyzed aminoalkynylation of alkynes

Chemical communications (Cambridge, England), 2016-01, Vol.52 (52), p.8152-8155

2016

Volltextzugriff (PDF)

ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer

Annals of oncology, 2022-05, Vol.33 (5), p.466-487

2022

Volltextzugriff (PDF)

Gold(i)-catalyzed cross-coupling reactions of aryldiazonium salts with organostannanes

Organic & biomolecular chemistry, 2018, Vol.16 (16), p.2865-2869

2018

Volltextzugriff (PDF)

Stage III Non-small Cell Lung Cancer: A UK National Survey of Practice

Clinical oncology (Royal College of Radiologists (Great Britain)), 2020-08, Vol.32 (8), p.527-536

2020

Volltextzugriff (PDF)

Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study

Annals of oncology, 2024-01, Vol.35 (1), p.77-90

2024

Volltextzugriff (PDF)

Interplay of Anion‐π+ and π+‐π+ Interactions in Novel Pyrido[2,1‐a]isoquinolinium‐Based AIEgens ‐ Substituent‐ and Counterion‐Dependent Fluorescence Modulation and Applications in Live Cell Mitochondrial Imaging

Chemistry : a European journal, 2022-07, Vol.28 (38), p.e202200632-n/a

2022

Volltextzugriff (PDF)

Photocatalytic degradation of dyes in water by analytical reagent grades ZnO, TiO2 and SnO2: a comparative study

Drinking water engineering and science, 2017-11, Vol.10 (2), p.109-117

2017

Volltextzugriff (PDF)

Gold‐Catalyzed Dehydrazinative C(sp)–S Coupling Reactions of Arylsulfonyl Hydrazides with Ethynylbenziodoxolones for Accessing Alkynyl Sulfones

European journal of organic chemistry, 2017-06, Vol.2017 (24), p.3512-3515

2017

Volltextzugriff (PDF)

Concurrent oral delivery of non-oncology drugs through solid self-emulsifying system for repurposing in hepatocellular carcinoma

Drug development and industrial pharmacy, 2023-05, Vol.49 (5), p.377-391

2023

Volltextzugriff (PDF)

Transformation to “high grade” neuroendocrine carcinoma as an acquired drug resistance mechanism in EGFR-mutant lung adenocarcinoma

Lung cancer (Amsterdam, Netherlands), 2013-04, Vol.80 (1), p.1-4

2013

Volltextzugriff (PDF)

Applications and advancements of nanoparticle-based drug delivery in alleviating lung cancer and chronic obstructive pulmonary disease

Naunyn-Schmiedeberg's archives of pharmacology, 2024-05, Vol.397 (5), p.2793-2833

2024

Volltextzugriff (PDF)

1 – 25 von 4.125

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.249)
Mit Volltextzugriff
(3.890)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.698)
Life Sciences & Biomedicine
(1.309)
Humans
(999)
Female
(523)
Male
(489)
Middle Aged
(418)
Oncology
(412)
Adult
(403)
Aged
(350)
Hematology
(348)
Technology
(292)
Hematology, Oncology And Palliative Medicine
(238)
Physical Sciences
(234)
Biological And Medical Sciences
(220)
Medical Sciences
(204)
Treatment Outcome
(189)
Transplantation
(186)
Retrospective Studies
(175)
Materials Science
(169)
Chemistry
(167)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(408)
Biology Of Blood And Marrow Transplantation
(207)
Lung Cancer
(138)
Journal Of Clinical Oncology
(130)
Journal Of Thoracic Oncology
(124)
Annals Of Oncology
(122)
Anaesthesia
(91)
Transplantation And Cellular Therapy
(79)
Clinical Lymphoma, Myeloma And Leukemia
(75)
British Journal Of Haematology
(54)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(40)

Menü

Weitere Dienste

Einstellungen

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Adjuvant immune checkpoint inhibitor therapy for resected non-small-cell lung cancer: dessert, starters, or a sandwich?

Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Brain metastases in solid tumours: new guidelines for a new era

Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis

ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial

First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743

FIELDimageR.Extra: Advancing user experience and computational efficiency for analysis of orthomosaic from agricultural field trials

Efficient access to alkynylated quinalizinones via the gold(i)-catalyzed aminoalkynylation of alkynes

ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer

Gold(i)-catalyzed cross-coupling reactions of aryldiazonium salts with organostannanes

Stage III Non-small Cell Lung Cancer: A UK National Survey of Practice

Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study

Interplay of Anion‐π+ and π+‐π+ Interactions in Novel Pyrido[2,1‐a]isoquinolinium‐Based AIEgens ‐ Substituent‐ and Counterion‐Dependent Fluorescence Modulation and Applications in Live Cell Mitochondrial Imaging

Photocatalytic degradation of dyes in water by analytical reagent grades ZnO, TiO2 and SnO2: a comparative study

Gold‐Catalyzed Dehydrazinative C(sp)–S Coupling Reactions of Arylsulfonyl Hydrazides with Ethynylbenziodoxolones for Accessing Alkynyl Sulfones

Concurrent oral delivery of non-oncology drugs through solid self-emulsifying system for repurposing in hepatocellular carcinoma

Transformation to “high grade” neuroendocrine carcinoma as an acquired drug resistance mechanism in EGFR-mutant lung adenocarcinoma

Applications and advancements of nanoparticle-based drug delivery in alleviating lung cancer and chronic obstructive pulmonary disease

Suchergebnisse filtern